Cargando…

Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysis

Colon cancer-associated transcript2 (CCAT2), a long noncoding RNA (LncRNA), has been found to function as an oncogene in various cancers. However, the clinical value of CCAT2 in cancers remains unclear. Therefore, we performed this meta-analysis to investigate the association between CCAT2 level and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dailian, Chen, Zhicong, Xu, Haidan, He, Anbang, Liu, Yuchen, Huang, Weiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650455/ https://www.ncbi.nlm.nih.gov/pubmed/29088900 http://dx.doi.org/10.18632/oncotarget.18161

Ejemplares similares

Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis
por: Chen, Zhicong, et al.
Publicado: (2016)

Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: a meta-analysis
por: He, Anbang, et al.
Publicado: (2016)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer
por: He, Anbang, et al.
Publicado: (2016)

Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
por: Cai, Yi, et al.
Publicado: (2015)

Long Noncoding RNA CCAT2 as a Potential Novel Biomarker to Predict the Clinical Outcome of Cancer Patients: A Meta-Analysis
por: Tan, Juan, et al.
Publicado: (2017)

Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016)

Recent development on synthetic biological devices treating bladder cancer
por: Chen, Zhicong, et al.
Publicado: (2016)

Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge
por: Deng, Liang, et al.
Publicado: (2015)

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma
por: Fang, Hua, et al.
Publicado: (2018)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Exploring the Molecular Mechanism and Biomakers of Liver Cancer Based on Gene Expression Microarray
por: Liu, Pengfei, et al.
Publicado: (2015)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

A miRNA- and mRNA-seq-Based Feature Selection Approach for Kidney Cancer Biomakers
por: Kim, Shinuk
Publicado: (2020)

Association of viral load with serum biomakers among COVID-19 cases
por: Shi, Fengjuan, et al.
Publicado: (2020)

Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population
por: Olesiński, Tomasz, et al.
Publicado: (2021)

Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Glioma Cells
por: Zeng, Jing, et al.
Publicado: (2017)

Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis
por: Gao, Qunjun, et al.
Publicado: (2017)

OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells
por: Wang, Dailian, et al.
Publicado: (2018)

Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer
por: Hua, Fu, et al.
Publicado: (2018)

Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis
por: Zhou, Daoping, et al.
Publicado: (2022)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
por: Yang, Zuozhang, et al.
Publicado: (2016)

Long Noncoding RNA PVT1 as a Novel Predictor of Metastasis, Clinicopathological Characteristics and Prognosis in Human Cancers: a Meta-Analysis
por: Liu, Congmin, et al.
Publicado: (2018)

Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
por: Liu, Congmin, et al.
Publicado: (2019)

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
por: Imperiali, Claudia E., et al.
Publicado: (2020)

Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Han, et al.
Publicado: (2017)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Long Noncoding RNA Plays a Key Role in Metastasis and Prognosis of Hepatocellular Carcinoma
por: Li, Guangbing, et al.
Publicado: (2014)

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer
por: Ling, Hui, et al.
Publicado: (2013)

Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2017)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

Long Noncoding RNA CCAT1 Functions as a Competing Endogenous RNA to Upregulate ITGA9 by Sponging MiR-296-3p in Melanoma
por: Fan, Jinghua, et al.
Publicado: (2020)

Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2016)

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells
por: Xie, Haibiao, et al.
Publicado: (2017)

Rab27a Was Identified as a Prognostic Biomaker by mRNA Profiling, Correlated with Malignant Progression and Subtype Preference in Gliomas
por: Wang, Hongjun, et al.
Publicado: (2014)

Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer
por: Li, Jianfa, et al.
Publicado: (2023)

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5vs2sbrsntdhsni7ibj92fv8iv